Biogenera
Bologna, IT · Founded 2008 · 22 employees on LinkedIn · 1 known investors
Find your way into Biogenera
Sign up to see every warm intro you have to Biogenera
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Biogenera team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Biogenera develops BGA002, an anti-tumor therapeutic candidate targeting neuroblastoma and rhabdomyosarcoma, which primarily affect children and adolescents. The company is advancing the drug through clinical development with a structured regulatory pathway in Europe.
Founders & leadership
Biogenera was founded in 2008 by Roberto Tonelli.
Investors · 1
Frequently asked questions
- What does Biogenera do?
- Biogenera develops BGA002, an anti-tumor therapeutic candidate targeting neuroblastoma and rhabdomyosarcoma, which primarily affect children and adolescents. The company is advancing the drug through clinical development with a structured regulatory pathway in Europe.
- Who founded Biogenera?
- Biogenera was founded by Roberto Tonelli in 2008.
- Who are Biogenera's investors?
- Biogenera's investors include Italian Angels for Growth.
- Where is Biogenera headquartered?
- Biogenera is headquartered in Bologna, IT.


